Zoe N. Memel M.D.,Jeffrey Wang B.S.,Kathleen E. Corey M.D., M.P.H., M.M.Sc.
First published: 03 February 2022
doi.org/10.100...
Potential conflict of interest: KC consults for Novo Nordisk. She also consults for and received grants from Bristol-Myers Squibb. ZM own stock in Novo Nordisk.
Негізгі бет Intermittent Fasting as a Treatment for Nonalcoholic Fatty Liver Disease: What Is the Evidence?
No video
Пікірлер: 57